Strattera withdrawal typically lasts one to four weeks after your final dose. You’ll usually notice symptoms within 24 to 72 hours, as atomoxetine clears your system within one to two days. Expect irritability, nausea, dizziness, and fatigue early on, with rebound ADHD symptoms and low mood peaking between days three and seven. Most effects resolve within four weeks. Your metabolism, dosage, and tapering approach all shape your timeline. Here’s what to expect next.
Key Takeaways
- Withdrawal symptoms typically begin within 24 to 72 hours after the final dose, as atomoxetine levels decline.
- Days 3 to 7 mark the peak severity of rebound symptoms, often including irritability, nausea, and low mood.
- Symptoms generally resolve within one to four weeks under supervised tapering.
- CYP2D6 poor metabolizers may need five to six weeks for full resolution.
- Persistence beyond four weeks is uncommon; consult your prescriber if symptoms continue.
How long do effects last after stopping Strattera
Strattera effects typically last one to four weeks after your final dose under supervised tapering. Withdrawal symptoms begin within 24 to 72 hours and resolve within that window. If you’re a CYP2D6 poor metabolizer, you may need five to six weeks for full resolution because your plasma half-life extends longer than the typical 5 hours. You’ll likely notice peak severity between days 3 and 7 after reduction. Rebound ADHD symptoms and low mood can persist for two to four weeks, though they’re uncommon beyond that window. Your dosage, treatment duration, and metabolic rate all influence how long effects last. If you have underlying mental health conditions, psychological symptoms like depression or anxiety may continue for several weeks. Tapering gradually shortens your total duration to one to three weeks.
What is Strattera’s half-life and how fast does it clear
Strattera has a half-life of roughly 5 hours in most individuals, though this ranges from 5 to 24 hours depending on your metabolic rate. After your last dose, plasma concentrations begin declining within 5 to 10 hours. Most people clear the drug within 1 to 2 days, with urine detection extending 1 to 3 days and blood detection up to 3 days post-discontinuation.
Your metabolism drives these numbers. If you’re a CYP2D6 poor metabolizer, your plasma half-life extends notably, delaying clearance and prolonging symptom resolution to five or six weeks. This explains why identical doses produce different withdrawal experiences. The speed at which your body eliminates atomoxetine directly shapes when symptoms emerge and how long they persist.
What a general day-by-day timeline looks like
A general day-by-day timeline runs from symptom onset within 24 to 72 hours to full resolution within four to six weeks. Within the first 24 to 72 hours after your final dose, withdrawal symptoms typically begin. You’ll likely notice irritability, nausea, or dizziness as plasma concentrations decline. Between days 3 and 7, symptoms often reach peak severity, particularly if you stopped abruptly. After the first week, intensity generally subsides, though rebound ADHD symptoms and low mood can linger.
| Timeframe | What You Can Expect |
|---|---|
| Days 1, 3 | Onset of irritability, nausea, dizziness, fatigue |
| Days 3, 7 | Peak severity of rebound symptoms |
| Weeks 1, 4 | Gradual resolution under supervised tapering |
| Weeks 5, 6 | Extended timeline for CYP2D6 poor metabolizers |
If you’re a poor metabolizer, you may need five to six weeks for full resolution due to extended plasma half-life.
When ADHD symptoms typically return
ADHD symptoms typically return within one to two days after your last dose, once the drug clears your system. This is the most noticeable change most patients report after stopping. Because atomoxetine clears within one to two days for most individuals, you’ll likely notice the return of unmanaged symptoms early in the discontinuation window. This isn’t withdrawal in the traditional sense, it’s the resurfacing of the condition the medication was treating.
- Days 1, 3: As plasma concentrations decline, focus and attention deficits begin re-emerging.
- Days 3, 7: Rebound symptoms peak, often accompanied by irritability or low mood.
- Weeks 1, 4: Rebound ADHD symptoms and low mood may persist during this period.
- Beyond 4 weeks: Persistence is uncommon, consult your prescriber if symptoms continue.
How long any mild transient effects tend to last
Mild transient effects like nausea, dizziness, fatigue, and irritability typically resolve within one to four weeks under supervised tapering. You’ll likely notice these symptoms emerge within 1 to 3 days after your last dose, with intensity peaking during the first week. If you stop abruptly, expect peak severity between days 3 and 7. Gradual tapering over 2 to 4 weeks produces milder symptoms without a sharp peak, often shortening the total duration to 1 to 3 weeks.
Your individual timeline depends on metabolic rate. If you’re a CYP2D6 poor metabolizer, you may need five to six weeks for full resolution due to extended plasma half-life. For most people, though, these physical effects clear quickly, leaving only the return of underlying ADHD symptoms to manage.
Why timelines vary by person and metabolism
Timelines vary by person because metabolism drives much of the variation you’ll see in withdrawal. Atomoxetine’s half-life ranges from 5 to 24 hours depending on how efficiently you clear the drug, which directly shapes how quickly symptoms emerge and resolve. Several factors determine your individual experience:
- CYP2D6 status: If you’re a poor metabolizer, extended plasma half-life can push full resolution to five or six weeks.
- Dosage: Higher doses before discontinuation typically prolong and intensify symptoms.
- Duration of use: Longer treatment periods can lengthen your overall timeline.
- Underlying conditions: Existing mental health issues may extend mood-related symptoms for several weeks.
Because these variables interact, your recovery won’t match anyone else’s precisely. Understanding your metabolic profile helps you anticipate a realistic timeline.
How Florida Sober Living Homes connects people to care
Florida Sober Living Homes connects you to care by matching you with clinicians who can supervise your Strattera discontinuation and manage the variable timeline your metabolism dictates. Because atomoxetine’s half-life ranges from 5 to 24 hours, and CYP2D6 poor metabolizers may need five to six weeks for full resolution, you benefit from individualized monitoring. We match you with providers who can assess whether abrupt cessation or a 2-to-4-week taper suits your history, dosage, and duration of use.
Our network tracks your symptoms through the days 3-to-7 peak window, addressing irritability, nausea, dizziness, fatigue, and rebound ADHD symptoms. If underlying depression or anxiety persists beyond expected timeframes, we coordinate ongoing psychiatric support. You get evidence-based supervision that reduces uncertainty and helps you complete discontinuation safely and predictably.
Get Support Through Strattera Discontinuation
Strattera withdrawal symptoms can vary from day to day, and some concerns may last longer than others as your body adjusts. Florida Sober Living Homes connects people with mental health support and recovery coaching and monitoring when returning ADHD symptoms, mood changes, or substance use concerns affect recovery. For confidential treatment referrals, contact the SAMHSA National Helpline at 1-800-662-HELP (4357).
Frequently Asked Questions
Can I Switch Directly From Strattera to Another ADHD Medication?
You can often switch directly, since the FDA label confirms Strattera doesn’t require tapering and no acute discontinuation syndrome occurs with abrupt cessation. However, don’t make this decision alone. Your prescriber must guide the transition. If you’re a CYP2D6 poor metabolizer, atomoxetine’s extended half-life means it’ll linger longer, so timing matters. Watch for transient effects like irritability, nausea, or dizziness during the crossover, and report any persistent mood changes promptly.
Does Strattera Withdrawal Cause Weight or Appetite Changes?
The available clinical data don’t specifically identify weight or appetite changes as documented atomoxetine discontinuation effects. You’re more likely to experience irritability, nausea, dizziness, and fatigue during withdrawal. That said, if you notice appetite shifts, they’re often linked to the return of unmanaged ADHD symptoms or underlying mood changes rather than the withdrawal itself. If you’re concerned about significant weight changes, you should discuss them with your prescriber.
Are There Any Dangerous or Life-Threatening Strattera Withdrawal Symptoms?
You won’t typically face life-threatening symptoms when stopping Strattera. The FDA label confirms no acute discontinuation syndrome occurs, even with abrupt cessation, and clinical trials in 3,000+ pediatric patients support its safety. You’ll more likely experience mild, transient effects like irritability, nausea, dizziness, and fatigue. However, watch your mood closely. If you have underlying depression or anxiety, these symptoms can persist or worsen, so contact your provider if concerning symptoms emerge.
Can I Drink Alcohol While Discontinuing Strattera?
The provided information doesn’t specifically address alcohol use during Strattera discontinuation. You should consult your prescribing physician before combining alcohol with any medication changes. Keep in mind that withdrawal symptoms like dizziness, fatigue, nausea, and irritability can overlap with alcohol’s effects, potentially intensifying discomfort during this period. Alcohol may also worsen mood-related symptoms such as depression or anxiety. For personalized guidance based on your metabolism and health status, contact your healthcare provider directly.
Does Strattera Withdrawal Affect Sleep or Cause Insomnia?
Strattera withdrawal doesn’t directly cause insomnia, but you might notice sleep disturbances tied to related symptoms. As atomoxetine clears, typically within one to two days, you may experience irritability, fatigue, or returning ADHD symptoms that can disrupt your rest. Underlying anxiety or mood changes during discontinuation can also affect your sleep quality for several weeks. If you’re struggling with persistent insomnia, you should consult your prescriber for individualized guidance.
